vindesine + streptozocin + cisplatin + prednisone

This combination consists of four individual chemotherapeutic and supportive agents: vindesine (a semisynthetic vinca alkaloid), streptozocin (an alkylating agent), cisplatin (a platinum-based alkylating agent), and prednisone (a corticosteroid). Each drug has a distinct mechanism of action and clinical use. This combination is not a marketed fixed-dose product but can be administered together as part of multi-agent chemotherapy regimens for certain malignancies, particularly when intensive treatment or symptomatic management is required. The regimen is not universally standardized and would be based on institutional or protocol-specific guidelines.